Case Report on an adolescent with polycystic ovarian disorder

Main Article Content

Ms. Sanjana Prakash Futane, Ms. Vaishali Balpande, Shital Telrandhe, S. R. Kapse,

Abstract

PCOD, or the most frequent endocrine-metabolic illness in reproductive-aged women is polycystic ovarian disorder (PCOD). Polycystic ovarian disorder is a complicated, heavily hereditary  condition. PCOD has been linked to pathophysiological changes in gonadotropin production and among other things, ovarian folliculogenesis, steroidogenesis, insulin production and action, and adipose tissue function. A collect history and physical examination, as well as an a hirsutism examination, ovarian ultrasound, and hormonal tests to confirm hyperandrogenism and oligo-anovulation if necessary. In PCOD, therapeutic decisions are based on the patient's phenotype, concerns, and goals, and should aim to inhibit and counteract androgen secretion and activity, improve metabolic status, and improve fertility. Despite tremendous advances in comprehending the causes as well as a diagnosis condition in comparison to last twenty years, many practitioners continue to misdiagnose and misunderstand the disorder. Clinical finding is menstrual abnormalities include irregular menstruation, menstrual absence, Spotting, heavy menstruation, irregular menstruation, brief and moderate menstruation, and spotting are all symptoms of menopause. Therapeutic intervention it is a combined oral contraceptive comprising 20g to 35 g of ethinyl estradiol is the first-line pharmacological management for teenagers with polycystic ovarian disorder. This technique are effective for both hirsutism and acne. Then output is given the considerable decreases in quality of life as it relates to health reported among the affected client, PCOD is becoming an increasingly relevant teenage reproductive health diagnosis. Then conclusion it is in the majority of the research in this review, the IDF definition was used, which is the most recent and is standardised for teenagers by age group. summarises data on metabolic disorder in women including and excluding polycystic ovarian disorder.

Article Details

Section
Articles